InfuSystem Holdings, Inc INFU

Latest FY: 2025 Healthcare Medical Devices
Market Price $12.24
Market Cap $251.87M
P/E Ratio 39.48
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑6.4% YoY
$143.44M
3-Yr CAGR: 9.3%
Net Income ↑182.6% YoY
$6.63M
Net Margin: 4.6%
Free Cash Flow ↑23.1% YoY
$23.85M
FCF Yield: 9.47%
EPS (Diluted) ↑181.8% YoY
$0.31
Basic: $0.32
Return on Equity Efficiency
11.6%
ROA: 18.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (INFU)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $70.5M $44.7M $-0.2M $-0.01 $7.9M $7.7M
FY 2017 $71.1M +0.8% $43.4M $-20.7M -9,227.5% $-0.91 -9,000.0% $7.6M $7.5M -3.4%
FY 2018 $10.6M -85.2% $39.0M $-1.1M +94.7% $-0.05 +94.5% $11.4M $11.1M +48.5%
FY 2019 $81.1M +668.6% $46.9M $1.4M +224.3% $0.07 +240.0% $13.9M $10.9M -1.4%
FY 2020 $97.4M +20.1% $58.8M $17.3M +1,173.5% $0.80 +1,042.9% $20.3M $19.2M +75.2%
FY 2021 $102.4M +5.1% $60.2M $1.4M -91.8% $0.06 -92.5% $18.3M $17.3M -9.6%
FY 2022 $109.9M +7.4% $62.6M $0.0M -98.7% -100.0% $17.5M $16.5M -4.6%
FY 2023 $125.8M +14.4% $63.1M $0.9M +4,744.4% $0.04 $11.2M $10.2M -38.3%
FY 2024 $134.9M +7.2% $70.4M $2.3M +168.9% $0.11 +175.0% $20.5M $19.4M +89.9%
FY 2025 $143.4M +6.4% $80.3M $6.6M +182.6% $0.31 +181.8% $24.4M $23.8M +23.1%
$

Valuation

Market Price $12.24
Market Cap $251.87M
Enterprise Value $268.31M
P/E Ratio 39.48
P/B Ratio 4.31
FCF Yield 9.47%
Dividend Yield N/A
Shares Outstanding 20,181,700
%

Profitability & Margins

Gross Margin 55.98%
Operating Margin 8.31%
Net Margin 4.62%
Return on Equity (ROE) 11.56%
Return on Assets (ROA) 18.24%
Asset Turnover 3.95x
Revenue 3-Yr CAGR 9.28%
🛡️

Financial Health & Liquidity

Current Ratio 1.80
Cash Ratio 0.16
Debt / Equity 0.342
Debt / Assets 0.540
Cash & Equivalents $3.19M
Total Debt $19.62M
Book Value / Share $2.84
💧

Cash Flow Efficiency

Operating Cash Flow $24.41M
Capital Expenditures (CapEx) $560.00K
Free Cash Flow $23.85M
OCF / Revenue 17.02%
FCF / Revenue 16.63%
FCF 3-Yr CAGR 12.98%
🏷️

Per Share Metrics

EPS (Diluted) $0.31
EPS (Basic) $0.32
Dividends / Share N/A
Book Value / Share $2.84
EPS YoY Growth 181.82%
🏛️

Balance Sheet (FY 2025)

Total Assets $36.34M
Total Liabilities $20.18M
Stockholders' Equity $57.33M
Current Assets $36.34M
Current Liabilities $20.18M